|
Volumn 509, Issue 7502, 2014, Pages
|
Therapy: This time it's personal
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
B RAF KINASE;
IMATINIB;
SMALL INTERFERING RNA;
VEMURAFENIB;
CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;
BONE MARROW TRANSPLANTATION;
CANCER IMMUNOTHERAPY;
CANCER THERAPY;
CHROMOSOME 15;
CHROMOSOME 17;
CHROMOSOME ANALYSIS;
HUMAN;
NEOPLASM;
NOTE;
ONCOGENE;
PRIORITY JOURNAL;
SCIENTIST;
BLOOD SAMPLING;
CANCER GROWTH;
CHROMOSOME TRANSLOCATION;
COMPUTER ASSISTED TOMOGRAPHY;
DNA FINGERPRINTING;
GENE REARRANGEMENT;
GENOTYPE;
LOSS OF FUNCTION MUTATION;
PERSONALIZED MEDICINE;
PROMYELOCYTIC LEUKEMIA;
RNA INTERFERENCE;
SHORT SURVEY;
CANCER;
CHROMOSOME;
DRUG;
HEALTH CARE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BENZAMIDES;
BIOLOGICAL EVOLUTION;
BIOPSY;
DISEASE PROGRESSION;
DNA MUTATIONAL ANALYSIS;
DNA, NEOPLASM;
DRUG DELIVERY SYSTEMS;
DRUG RESISTANCE, NEOPLASM;
GENES, TUMOR SUPPRESSOR;
GENETICS, MEDICAL;
GENOMICS;
HUMANS;
IMMUNOTHERAPY;
INDIVIDUALIZED MEDICINE;
INDOLES;
LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE;
MIDDLE AGED;
NANOPARTICLES;
NEOPLASMS;
PHARMACOGENETICS;
PIPERAZINES;
PROTO-ONCOGENE PROTEINS B-RAF;
PYRIMIDINES;
RNA INTERFERENCE;
RNA, SMALL INTERFERING;
SULFONAMIDES;
TIME FACTORS;
TRANSCRIPTOME;
|
EID: 84901586904
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/509S52a Document Type: Note |
Times cited : (10)
|
References (6)
|